{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:20:23Z","timestamp":1783225223428,"version":"3.54.6"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neuropharm.2013.10.032","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T19:17:06Z","timestamp":1383851826000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABAA and GABAB receptor activation"],"prefix":"10.1016","volume":"79","author":[{"given":"Douma","family":"TN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millan","family":"MJ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verdouw","family":"PM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oosting","family":"RS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"B","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Groenink","family":"L","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.10.032_bib1","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1038\/npp.2008.41","article-title":"Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen","volume":"33","author":"Arai","year":"2008","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainresbull.2007.07.003","article-title":"The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala \u2013 an in\u00a0vitro superfusion study","volume":"75","author":"Bagosi","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1476-5381.2010.01199.x","article-title":"Glucocorticosteroids: current and future directions","volume":"163","author":"Barnes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2004.05.034","article-title":"Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells","volume":"495","author":"Basta-Kaim","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004714-200110000-00009","article-title":"Rapid reversal of psychotic depression using mifepristone","volume":"21","author":"Belanoff","year":"2001","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/mp.2009.141","article-title":"The CRF system, stress, depression and anxiety-insights from human genetic studies","volume":"15","author":"Binder","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00213-003-1589-5","article-title":"Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomorphine","volume":"171","author":"Bortolato","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-007-0845-5","article-title":"Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA\/2J mice","volume":"194","author":"Bortolato","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0447.2005.00522.x","article-title":"Valproate in bipolar disorder: 2000 onwards","volume":"426","author":"Bowden","year":"2005","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1469-8986.1978.tb01390.x","article-title":"Prestimulus effects on human startle reflex in normals and schizophrenics","volume":"15","author":"Braff","year":"1978","journal-title":"Psychophysiology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib11","first-page":"11","article-title":"Advances in endophenotyping schizophrenia","volume":"7","author":"Braff","year":"2008","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. (WPA)"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2012.05.004","article-title":"A\u00a0theoretical framework informing research about the role of stress in the pathophysiology of bipolar disorder","volume":"39","author":"Brietzke","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib13","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1111\/j.1460-9568.2003.03073.x","article-title":"Disruption of prepulse inhibition in mice lacking mGluR1","volume":"12","author":"Brody","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(03)01285-8","article-title":"Neuroendocrine pharmacology of stress","volume":"463","author":"Carrasco","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-2999(01)01494-7","article-title":"GABA(B) receptor inhibition causes locomotor stimulation in mice","volume":"433","author":"Colombo","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1037\/0735-7044.119.4.1052","article-title":"Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain","volume":"119","author":"Conti","year":"2005","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.physbeh.2004.06.013","article-title":"Stress induces CRF release in the paraventricular nucleus, and both CRF and GABA release in the amygdala","volume":"82","author":"Cook","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1471-4159.2005.03164.x","article-title":"Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists","volume":"94","author":"de Groote","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib19","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1046\/j.1460-9568.2002.02245.x","article-title":"Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations","volume":"16","author":"Dirks","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib20","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/sj.npp.1300256","article-title":"Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs","volume":"28","author":"Dirks","year":"2003","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-012-2904-9","article-title":"Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system","volume":"226","author":"Egashira","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00213-004-1875-x","article-title":"Effects of ethanol and GABAB drugs on working memory in C57BL\/6J and DBA\/2J mice","volume":"176","author":"Escher","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib23","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/npp.2008.225","article-title":"Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: involvement of nitric oxide","volume":"34","author":"Fejgin","year":"2009","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-009-1547-y","article-title":"Mood stabilizers increase prepulse inhibition in DBA\/2NCrl mice","volume":"205","author":"Flood","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/jpet.102.045419","article-title":"The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems","volume":"305","author":"Gilmor","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib26","first-page":"914","article-title":"Indirect evidence to suggest that prolactin mediates the adrenal action of haloperidol to stimulate aldosterone and corticosterone secretion in rats","volume":"130","author":"Goebel","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/FBP.0b013e3283512c56","article-title":"Effects of vigabatrin, an irreversible GABA transaminase inhibitor, on ethanol reinforcement and ethanol discriminative stimuli in mice","volume":"23","author":"Griffin","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biopsych.2007.06.002","article-title":"CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF","volume":"63","author":"Groenink","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0006-3223(02)01334-3","article-title":"HPA axis dysregulation in mice overexpressing corticotropin releasing hormone","volume":"51","author":"Groenink","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0091-3057(95)02177-9","article-title":"Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice","volume":"54","author":"Groenink","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.mp.4001554","article-title":"Hippocampal alpha5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition","volume":"10","author":"Hauser","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib31","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/sj.npp.1301038","article-title":"Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects","volume":"31","author":"Herringa","year":"2006","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib32","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00517-8","article-title":"Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation","volume":"380","author":"Ichikawa","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20050466","article-title":"Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression","volume":"203","author":"Ito","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nlm.2012.03.005","article-title":"Histone acetylation rescues contextual fear conditioning in nNOS KO mice and accelerates extinction of cued fear conditioning in wild type mice","volume":"97","author":"Itzhak","year":"2012","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentary","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib36","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of alzheimer's disease","volume":"35","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib37","doi-asserted-by":"crossref","first-page":"12927","DOI":"10.1523\/JNEUROSCI.2887-08.2008","article-title":"Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons","volume":"28","author":"Kirby","year":"2008","journal-title":"J.\u00a0Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib38","first-page":"RA1","article-title":"Targets for antiepileptic drugs in the synapse","volume":"13","author":"Landmark","year":"2007","journal-title":"Med. Sci. Monitor: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/mp.2009.39","article-title":"Neurobiological trait abnormalities in bipolar disorder","volume":"14","author":"Langan","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib40","doi-asserted-by":"crossref","first-page":"e45618","DOI":"10.1371\/journal.pone.0045618","article-title":"Valproate alters dopamine signaling in association with induction of par-4 protein expression","volume":"7","author":"Lee","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-3565(25)23855-1","article-title":"Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock","volume":"235","author":"Lloyd","year":"1985","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1568026611109060609","article-title":"The role of corticotropin-releasing hormone in the pathophysiology of depression: therapeutic implications","volume":"11","author":"Lloyd","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib44","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1523\/JNEUROSCI.3308-11.2012","article-title":"Epigenetic modulation of homer1a transcription regulation in amygdala and hippocampus with pavlovian fear conditioning","volume":"32","author":"Mahan","year":"2012","journal-title":"J.\u00a0Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0278-5846(92)90062-J","article-title":"GABA receptor alterations after chronic lithium administration. comparison with carbamazepine and sodium valproate","volume":"16","author":"Motohashi","year":"1992","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"issue":"Suppl.\u00a013","key":"10.1016\/j.neuropharm.2013.10.032_bib46","first-page":"19","article-title":"An ever-increasing pharmacopoeia for the management of patients with bipolar disorder","volume":"61","author":"Nemeroff","year":"2000","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib47","first-page":"1","article-title":"Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response","author":"Nikisch","year":"2011","journal-title":"Int. J. Neuropsychopharmacol.\/Off. Sci. J. Coll. Int. Neuropsychopharmacol. (CINP)"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib48","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/jpet.105.090845","article-title":"An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition","volume":"315","author":"Ong","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib49","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1523\/JNEUROSCI.5740-03.2004","article-title":"Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders","volume":"24","author":"Rainnie","year":"2004","journal-title":"J.\u00a0Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psyneuen.2010.07.002","article-title":"Cortisol rapidly disrupts prepulse inhibition in healthy men","volume":"36","author":"Richter","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00213-003-1535-6","article-title":"Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice","volume":"170","author":"Risbrough","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tem.2006.10.009","article-title":"Claims for mifepristone in neuropsychiatric disorders: commentary on DeBattista and Belanoff, and Neigh and Nemeroff","volume":"17","author":"Rubin","year":"2006","journal-title":"Trends Endocrinol. Metabol. TEM"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0022-3956(85)90068-8","article-title":"A\u00a0corticosteroid\/dopamine hypothesis for psychotic depression and related states","volume":"19","author":"Schatzberg","year":"1985","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopsych.2006.06.036","article-title":"Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse","volume":"62","author":"Schroeder","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib55","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1517\/14728210903413522","article-title":"Drugs in the medical treatment of Cushing's syndrome","volume":"14","author":"Schteingart","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib56","first-page":"CD004028","article-title":"Valproate for schizophrenia","author":"Schwarz","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0893-133X(00)00243-8","article-title":"Effects of sodium valproate on corticotropin-releasing factor systems in rat brain","volume":"24","author":"Stout","year":"2001","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0006-8993(90)91754-5","article-title":"GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats","volume":"532","author":"Swerdlow","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib59","first-page":"459","article-title":"Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in\u00a0vitro: evidence for the involvement of GABAergic neurotransmission","volume":"29","author":"Tringali","year":"2004","journal-title":"J.\u00a0Psychiatry Neurosci. JPN"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2006.09.050","article-title":"Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice","volume":"553","author":"Umeda","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib61","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00213-011-2423-0","article-title":"Lifelong CRF overproduction is associated with altered gene expression and sensitivity of discrete GABA(A) and mGlu receptor subtypes","volume":"219","author":"Vinkers","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.032_bib62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.clinpsy.4.022007.141248","article-title":"Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia","volume":"4","author":"Walker","year":"2008","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2013.10.032_bib63","doi-asserted-by":"crossref","first-page":"17154","DOI":"10.1073\/pnas.0508752102","article-title":"A\u00a0schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction","volume":"102","author":"Yee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081300508X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081300508X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T19:50:46Z","timestamp":1746042646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081300508X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":64,"alternative-id":["S002839081300508X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.032","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABAA and GABAB receptor activation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}